Literature DB >> 30296331

Presbyopic Excimer Laser Ablation: A Review.

Larissa R Stival, Marisa N Figueiredo, Marcony R Santhiago.   

Abstract

PURPOSE: To provide an overview of the efficacy and safety of available presbyopic excimer laser ablation profiles.
METHODS: Literature review.
RESULTS: Monovision with excimer laser traditionally applies near correction to the non-dominant eye. Different excimer laser presbyopic approaches include the increase in depth of focus, through the controlled change of spherical aberration or asphericity, or multifocal ablation patterns with central or peripheral near vision zones. The studies investigating different excimer laser ablation patterns applied in previously myopic eyes revealed high levels of efficacy with all ablation profiles (between 68% and 99% achieving binocular uncorrected distance visual acuity [UDVA] of 20/25 or better, and between 70% and 100% achieving uncorrected near visual acuity [UNVA] presenting J3 or better). In hypermetropic eyes, most of the studies revealed high levels of efficacy with different platforms (between 78% and 100% achieving binocular UDVA of 20/25 or better and between 70% and 100% achieving UNVA presenting J3 or better). Loss of two or more lines of corrected distance visual acuity varied between 0% and 10% in the myopic eyes and between 0% and 14% in the hyperopic eyes.
CONCLUSIONS: There is evidence that excimer laser presbyopic strategies accomplish spectacle independence at reasonable levels. There are reliable and safe options for both myopic and hyperopic eyes with satisfactory outcomes regarding near and distance vision. [J Refract Surg. 2018;34(10):698-710.]. Copyright 2018, SLACK Incorporated.

Entities:  

Mesh:

Year:  2018        PMID: 30296331     DOI: 10.3928/1081597X-20180726-02

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  4 in total

1.  Performance and Safety of the Extended Depth of Focus Implantable Collamer® Lens (EDOF ICL) in Phakic Subjects with Presbyopia.

Authors:  Mark Packer; Jose F Alfonso; Jaime Aramberri; Daniel Elies; Joaquin Fernandez; Erik Mertens
Journal:  Clin Ophthalmol       Date:  2020-09-18

Review 2.  PresbyLASIK: A review of PresbyMAX, Supracor, and laser blended vision: Principles, planning, and outcomes.

Authors:  Rohit Shetty; Sheetal Brar; Mohita Sharma; Zelda Dadachanji; Vaitheeswaran Ganesan Lalgudi
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

Review 3.  Presbyopia - A Review of Current Treatment Options and Emerging Therapies.

Authors:  James A Katz; Paul M Karpecki; Alexandra Dorca; Sima Chiva-Razavi; Heather Floyd; Elizabeth Barnes; Mark Wuttke; Eric Donnenfeld
Journal:  Clin Ophthalmol       Date:  2021-05-24

4.  Presbyopia Treatment With Eye Drops: An Eight Year Retrospective Study.

Authors:  Giovanna Benozzi; Cristian Perez; Juliana Leiro; Sonia Facal; Betina Orman
Journal:  Transl Vis Sci Technol       Date:  2020-06-23       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.